167 related articles for article (PubMed ID: 11442851)
1. Antifungal activity of histatin-5 against non-albicans Candida species.
Nikawa H; Jin C; Fukushima H; Makihira S; Hamada T
Oral Microbiol Immunol; 2001 Aug; 16(4):250-2. PubMed ID: 11442851
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5.
Nikawa H; Jin C; Makihira S; Hamada T; Samaranayake LP
J Prosthet Dent; 2002 Sep; 88(3):263-7. PubMed ID: 12426495
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
4. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species.
Tsai H; Bobek LA
Antimicrob Agents Chemother; 1997 Oct; 41(10):2224-8. PubMed ID: 9333052
[TBL] [Abstract][Full Text] [Related]
5. Internalisation and degradation of histatin 5 by Candida albicans.
Ruissen AL; Groenink J; Krijtenberg P; Walgreen-Weterings E; van 't Hof W; Veerman EC; Nieuw Amerongen AV
Biol Chem; 2003 Jan; 384(1):183-90. PubMed ID: 12674513
[TBL] [Abstract][Full Text] [Related]
6. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins.
Helmerhorst EJ; Venuleo C; Beri A; Oppenheim FG
Yeast; 2005 Jul; 22(9):705-14. PubMed ID: 16034806
[TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides.
Helmerhorst EJ; Reijnders IM; van't Hof W; Simoons-Smit I; Veerman EC; Amerongen AV
Antimicrob Agents Chemother; 1999 Mar; 43(3):702-4. PubMed ID: 10049295
[TBL] [Abstract][Full Text] [Related]
9. Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.
Gyurko C; Lendenmann U; Troxler RF; Oppenheim FG
Antimicrob Agents Chemother; 2000 Feb; 44(2):348-54. PubMed ID: 10639361
[TBL] [Abstract][Full Text] [Related]
10. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.
Rothstein DM; Spacciapoli P; Tran LT; Xu T; Roberts FD; Dalla Serra M; Buxton DK; Oppenheim FG; Friden P
Antimicrob Agents Chemother; 2001 May; 45(5):1367-73. PubMed ID: 11302797
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
12. Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.
Helmerhorst EJ; Venuleo C; Sanglard D; Oppenheim FG
Antimicrob Agents Chemother; 2006 Mar; 50(3):1100-3. PubMed ID: 16495279
[TBL] [Abstract][Full Text] [Related]
13. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
14. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species.
Helmerhorst EJ; Troxler RF; Oppenheim FG
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14637-42. PubMed ID: 11717389
[TBL] [Abstract][Full Text] [Related]
15. Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans.
Tsai H; Bobek LA
Biochim Biophys Acta; 1997 Oct; 1336(3):367-9. PubMed ID: 9367163
[TBL] [Abstract][Full Text] [Related]
16. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.
Hospenthal DR; Beckius ML; Floyd KL; Horvath LL; Murray CK
Ann Clin Microbiol Antimicrob; 2006 Jan; 5():1. PubMed ID: 16390552
[TBL] [Abstract][Full Text] [Related]
17. Killing of Candida albicans by histatin 5: cellular uptake and energy requirement.
Gyurko C; Lendenmann U; Helmerhorst EJ; Troxler RF; Oppenheim FG
Antonie Van Leeuwenhoek; 2001 Sep; 79(3-4):297-309. PubMed ID: 11816973
[TBL] [Abstract][Full Text] [Related]
18. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.
Helmerhorst EJ; Breeuwer P; van't Hof W; Walgreen-Weterings E; Oomen LC; Veerman EC; Amerongen AV; Abee T
J Biol Chem; 1999 Mar; 274(11):7286-91. PubMed ID: 10066791
[TBL] [Abstract][Full Text] [Related]
19. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
[TBL] [Abstract][Full Text] [Related]
20. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
